In the year 2000, ClinicalTrials.gov was launched with just 1,255 clinical trials listed. Fast-forward to today, and that number has grown to over 520,000, reflecting not only the acceleration of biomedical research but also the growing…
For decades, clinical trials have struggled with a deep-rooted problem: a lack of diversity. Racial and ethnic minorities, individuals in non-English-speaking communities, and patients outside of research-heavy geographies remain consistently underrepresented in studies. This isn’t just…
Bringing a new treatment or drug to market remains a time-consuming and expensive process, often taking over a decade and costing billions of dollars. Despite the best efforts of researchers, more than 80% of clinical trials…
For decades, space exploration has pushed the boundaries of human knowledge, allowing us to better understand our universe. The International Space Station (ISS), which has been orbiting Earth since 1998, serves as a unique research laboratory,…
For centuries, we’ve gazed at the stars, dreaming of space travel. Today, that dream is a reality, with astronauts spending months aboard the International Space Station, living and working in a world without gravity. The recent…
The clinical trial industry has undergone a radical transformation over the last decade. Historically, trial participants were often seen as mere data points, rather than being considered as active collaborators in research. Many trials were designed…
Imagine this: It’s 2035, and the first humans have just set foot on Mars. But instead of celebrating, they face a serious problem—half the crew struggles to walk because their muscles and bones have weakened after…